Lallemand Pharma
CH-MF-000036587 · Switzerland · Massagno
Lallemand Pharma is registered in the European database on medical devices as a manufacturer, with 13 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
| Class IIa | 13 |
|---|
Most frequent device types declared: Bag on Valve Nasal Spray, Nasal Pump Spray.
Authorised representative in the Union: ASPE CONSEIL.
Devices declared under this manufacturer
- Azéol DM Rhinite Rhinosinusite
- Azéol DM Rhume - Rhinite enfant
- Azéol DM Rhume Rhinite Enfant
- Azéol DM Rhume – Rhinite
- Healsea Babykids
- Healsea Dual
- Healsea Rescue
- Medenosin
- Medenosin Babykids
- Medenosin babykids
Showing 12 of 13 declared devices.
Catalogue references include 75011DLNR, 75014DJNA, 75014DJNK, 75014DJNP, 75015DJMS, 75015DJNE.
European nomenclature codes declared: Q030103.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 13 |
| Country of registration | Switzerland |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 13 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. Lallemand Pharma was not found in either the U.S. or the Canadian register.
Notified body certificates
| Certificate | Status | Expiry |
|---|---|---|
40179 | supplemented | 2030-03-18 |